7 th IAS Conference on HIV Pathogenesis, Treatment and Prevention IAS-NIDA RESEARCH FELLOWSHIP Encouraging HIV and Drug Use Research ANNOUNCEMENT OF 2013 Fellows Françoise Barré Sinoussi 2 July 2013

7 th IAS Conference on HIV Pathogenesis, Treatment and Prevention  Francis Bajunirwe, Uganda, Mbarara University  Project: Impact of alcohol consumption and other substances on response to antiretroviral treatment in rural Uganda  Mentor: David Bangsberg, Harvard Medical School, USA

7 th IAS Conference on HIV Pathogenesis, Treatment and Prevention  Sin How Lim, Malaysia, University of Malaysia  Project: Behavioural data collection using mobile health technologies: Concurrency of substance use and sexual risk behaviors among men who have sex with men (MSM) in Malaysia  Mentor: Frederick Altice, Yale University, USA

7 th IAS Conference on HIV Pathogenesis, Treatment and Prevention  Anh Dam Tran, Vietnam, University of New South Wales  Project: Should the methadone maintenance treatment (MMT) eligibility criteria for drug users in Vietnam be less stringent? Impact of expanding MMT programme on drug use, health-related quality of life, and HIV transmission in Vietnam: A combination of a dynamic epidemic model and a quality of life cross-sectional survey  Mentor: Greg Zaric, University of Western Ontario, Canada.

7 th IAS Conference on HIV Pathogenesis, Treatment and Prevention  Bach Xuan Tran, Vietnam, Hanoi Medical University  Project: Cost-effectiveness and willingness-to-pay for standalone, integrative and satellite models of dispensing methadone for the treatment of opioid dependence in Vietnam  Mentor: Carl Latkin, John Hopkins University, USA.

7 th IAS Conference on HIV Pathogenesis, Treatment and Prevention More information at and at the IAS booth. The International AIDS Society, the U.S. National Institute on Drug Abuse and the French National Agency for Research on AIDS and Viral Hepatitis are supporting a new round of research fellowships focusing on the linkages between HIV and drug use. This fellowship programme consists of two types of awards worth USD 75,000 aimed at:  Junior scientists with a doctoral degree (e.g., PhD, MD) for 18 months of post- doctoral training.  Well-established HIV or drug use researchers, not involved in HIV-related drug use research, for eight months professional development training.